Canada's Northwest Healthcare Q2 revenue falls nearly 17%

Reuters
08/13
Canada's Northwest Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> revenue falls nearly 17%

Overview

  • Northwest Healthcare Q2 2025 revenue falls 16.9% to C$99 million due to asset sales

  • Net income for Q2 2025 reaches C$32.6 mln, reversing prior year loss

  • Co suspends DRIP and appoints CEO Zachary Vaughan to Board

Outlook

  • Company manages rent deferral with Healthscope, expecting repayment by March 2026

Result Drivers

  • ASSET SALES - Revenue decreased 16.9% in Q2 2025 due to non-core asset sales, partially offset by same property revenue growth

  • SPNOI GROWTH - Same Property Net Operating Income increased by 2.8% driven by inflationary rent adjustments and improved recoveries

  • DEBT REDUCTION - Proceeds from asset sales used to repay debt, reducing leverage to 48.5% from 50.0% at year-end 2024

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Net Income

C$32.62 mln

Q2 FFO Per Share

C$0.11

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialized reits peer group is "buy."

  • Wall Street's median 12-month price target for Northwest Healthcare Properties REIT is C$5.55, about 14.2% above its August 11 closing price of C$4.76

Press Release: ID:nNFC5HMZvh

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10